Company Filing History:
Years Active: 2024-2025
Title: Ashwin Viswanathan: Innovator in Brain Stimulation Technologies
Introduction
Ashwin Viswanathan is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of brain stimulation technologies, holding 2 patents that focus on innovative methods for determining stimulation parameters and locating implantation sites in the brain.
Latest Patents
His latest patents include a "System and method for determining deep brain stimulation parameters." This method involves applying Low Frequency Stimulation (LFS) to a multi-contact electrode implanted in a target structure in an individual's brain. The Evoked Compound Activity (ECA) is measured, and a range of frequencies for delivering brain stimulation is determined based on a phase space extracted from the ECA. Stimulation frequencies are then applied, and High Frequency Oscillations (HFO) evoked by these frequencies are measured to select an effective treatment frequency.
Another significant patent is the "System and method for locating an implantation site in the brain." This method entails inserting multiple multi-contact electrodes into a target structure in the brain. High Frequency Stimulation (HFS) is applied, and both HFO and ECA are measured to identify a suitable site for electrode implantation based on predetermined thresholds.
Career Highlights
Ashwin Viswanathan is affiliated with the University of Houston System, where he continues to advance research in brain stimulation technologies. His work is pivotal in enhancing the understanding and treatment of neurological conditions.
Collaborations
He collaborates with esteemed colleagues such as Nuri F Ince and Musa Ozturk, contributing to a dynamic research environment focused on innovative solutions in neuroscience.
Conclusion
Ashwin Viswanathan's contributions to brain stimulation technologies exemplify the impact of innovative thinking in medical science. His patents reflect a commitment to improving treatment methodologies for neurological disorders.